Get started
Author

Małgorzata Raźny

Observed names: M Raźny, M. Razny, M. Raźny, Malgorzata Razny, Malgorzata Raźny, Małgorzata Razny, Małgorzata Raźny, Razny, M., Raźny, Małgorzata
ORCID: 0000-0001-8503-6114
Observed ORCID: 0000-0001-8503-6114
OpenAlex ID: A5070569444
Characteristics and outcomes of patients with multiple myeloma aged 21–40 years versus 41–60 years: a multi‐institutional case‐control study
2016 · Artur Jurczyszyn, Hareth Nahi, et al. · British Journal of Haematology · 43
Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial
2017 · Agnieszka Pluta, Tadeusz Robak, et al. · American Journal of Hematology · 26
PDF
Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia
2011 · Grzegorz Helbig, Andrzej Moskwa, et al. · Cancer Chemotherapy and Pharmacology · 24
PDF
Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases
2018 · Artur Jurczyszyn, Julio Davila, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 21
Genetically determined telomere length and multiple myeloma risk and outcome
2021 · Matteo Giaccherini, Angelica Macauda, et al. · Blood Cancer Journal · 20
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization
2023 · Esther Clavero, José Manuel Sanchez-Maldonado, et al. · International Journal of Molecular Sciences · 18
Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients
2018 · Angelica Macauda, Eleonora Castelli, et al. · British Journal of Haematology · 17
PDF
Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study
2014 · Bozena Katarzyna Budziszewska, Agnieszka Pluta, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 13
Identification of novel genetic loci for risk of multiple myeloma by functional annotation
2023 · Angelica Macauda, Klara Briem, et al. · Leukemia · 12
PDF
A polygenic risk score for multiple myeloma risk prediction
2021 · Federico Canzian, Chiara Piredda, et al. · European Journal of Human Genetics · 12
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients
2021 · Angelica Macauda, Chiara Piredda, et al. · International Journal of Cancer · 12
Identification of miRSNPs associated with the risk of multiple myeloma
2016 · Angelica Macauda, Diego Calvetti, et al. · International Journal of Cancer · 12
PDF
Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG)
2021 · Bożena Katarzyna Budziszewska, Aleksander Salomon-Perzyński, et al. · Cancers · 10
PDF
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with probable mesentery involvement with associated hemophagocytic syndrome (HPS) – how to treat it?
2020 · Agnieszka Giza, Krystyna Gałązka, et al. · Journal of Dermatological Treatment · 10
Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium
2019 · Elżbieta Iskierka-Jażdżewska, Federico Canzian, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 10
High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study Group
2019 · Iwona Hus, Joanna Mańko, et al. · Oncology Letters · 9
PDF
The proportion of CD3− CD4+ T‐cell population remained unaffected after corticosteroids treatment for lymphocytic variant hypereosinophilic syndrome (L‐HES)
2010 · G. Helbig, R. Wichary, et al. · Scandinavian Journal of Immunology · 9
PDF
The Efficacy of Cladribine (2-CdA) in Advanced Systemic Mastocytosis
2020 · Grzegorz Helbig, Anna Koclęga, et al. · Indian Journal of Hematology and Blood Transfusion · 7
PDF
Cereblon (CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium
2014 · Elzbieta Iskierka-Jazdzewska, Anna Stepien, et al. · Blood · 6
Common gene variants within 3′‐untranslated regions as modulators of multiple myeloma risk and survival
2020 · Ombretta Melaiu, Angelica Macauda, et al. · International Journal of Cancer · 5
PDF
The Role of Lifestyle and Environmental Factors in the Pathogenesis of Multiple Myeloma
2025 · Anna Suska, Agata Tyczyńska, et al. · European Journal Of Haematology · 4
PDF
Bendamustine-Based Regimens as Salvage Therapy in Refractory/Relapsed Multiple Myeloma Patients: A Retrospective Real-Life Analysis by the Polish Myeloma Group
2021 · Norbert Grzasko, Grzegorz Charlinski, et al. · Journal of Clinical Medicine · 4
PDF
Pixantrone, etoposide, bendamustine, rituximab (P[R]EBEN) as an effective salvage regimen for relapsed/refractory aggressive non-Hodgkin lymphoma—Polish Lymphoma Research Group real-life analysis
2019 · Monika Długosz-Danecka, Iwona Hus, et al. · Pharmacological Reports · 4
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?
2022 · Angelica Macauda, Alyssa Clay-Gilmour, et al. · Cancer Epidemiology Biomarkers & Prevention · 3
Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)
2019 · Agnieszka Pluta, Tadeusz Robak, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 3
Works count: 59
Citation count: 328
H-index: 12
I10-index: 15
Year
Topic
Type